Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Liver Diseases of Pregnancy
In what scenario do you continue surveillance of benign liver tumors, e.g., hepatocellular adenoma, in pregnant patients?
Related Questions
How do you approach fertility/family planning and counseling in patients with end-stage liver disease?
What management considerations do you keep in mind in the management of pregnant patients with autoimmune liver disease?
How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?
How do you balance infection risk in patients with immune-mediated liver disease on chronic immunosuppression (ex: prednisone, AZA, MMF, etc)?
Is there benefit to aggressively treating hemochromatosis in a patient who has already progressed to cirrhosis at the time of diagnosis?
In what scenarios do you defer treatment of a patient's hepatitis C if they are undergoing liver transplant evaluation?
How do you balance infection risk versus therapeutic benefit of steroid tapers when treating patients with alcohol related hepatitis?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?
How do you utilize Cystatin-C as a marker of renal dysfunction in patients with chronic liver disease?
